Advertisement

Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x100px
Organisation › Details

BRAIN Biotech AG

BRAIN Biotech AG (“BRAIN”) is a leading European industrial biotechnology specialist with a focus on nutrition, health and the environment. As a technology and solutions provider the company supports the biologization of industries with bio-based products and processes. From contract R&D with industrial partners to advancing own disruptive incubator projects and customized enzyme products – BRAIN’s broad cutting-edge biotech expertise and its agile teams are key to success. BRAIN Biotech AG, Germany, is the parent company of the international BRAIN Group, distributing specialty B2B products like enzymes or bioactive natural products. The BRAIN Group has its own fermentation or production facilities in Continental Europe, UK and the US, which together with the associated biotechnological solution competency complete the value chain within the group. As a Participant of the United Nations Global Compact, BRAIN Biotech AG is committed to aligning strategies and operations with universal principles on human rights, labour, environment and anti-corruption and to actively advance common societal goals. Our products and services target at least five of the UN SDGs directly. Since its IPO in 2016, BRAIN Biotech AG is listed in the Prime Standard of the Frankfurt Stock Exchange (ISIN DE0005203947 / WKN 520394). *

 

Period Start 2021-05-12 renamed before
  Group BRAIN Biotech (Group)
  Predecessor BRAIN Biotechnology Reserarch and Information Network AG (FSE: BNN)
Products Industry BIOTECH
  Industry 2 WHITE BIOTECHNOLOGY
Persons Person Moelker, Adriaan (BRAIN 202002– CEO before Flint Group + AB Enzymes + Genencor + DSM)
  Person 2 Krohn, Michael (BRAIN Biotech 202210– RnD Head of Akribion Genomics before RnD Head of BRAIN Biotech AG)
     
Region Region Zwingenberg
  Country Germany
  Street 34-36 Darmstädter Str.
  City 64673 Zwingenberg
    Address record changed: 2022-09-17
     
Basic data Employees D: 101 to 500 (2022-09-30)
  Currency EUR
  Annual sales 49,509,000 (revenues, consolidated (2021/22) 2022-09-30)
  Profit -6,341,000 (2022-09-30)
  Cash 8,443,000 (2022-09-30)
     
    * Document for »About Section«: BRAIN Biotech AG. (5/30/22). "Press Release: Prof. Dr. Bernhard Hauer Leaves Supervisory Board of BRAIN Biotech AG for personal reasons". Zwingenberg.
     
   
Record changed: 2023-12-30

Advertisement

Picture EBD Group Bio-Europe Spring 2024 Barcelona 650x200px

More documents for BRAIN Biotech (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x300px




» top